The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG). (Record no. 18285732)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02154 a2200613 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250515140054.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200902s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1476-5551 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1038/leu.2008.261 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Buske, C |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20090206 |
| 245 00 - TITLE STATEMENT | |
| Title | The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG). |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Leukemia |
| Date of publication, distribution, etc. | Jan 2009 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 153-61 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Murine-Derived |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cyclophosphamide |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Doxorubicin |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prednisone |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Remission Induction |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Rituximab |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Vincristine |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Waldenstrom Macroglobulinemia |
| General subdivision | drug therapy |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hoster, E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dreyling, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Eimermacher, H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wandt, H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Metzner, B |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fuchs, R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bittenbring, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Woermann, B |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hohloch, K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hess, G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ludwig, W-D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schimke, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schmitz, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kneba, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Reiser, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Graeven, U |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Klapper, W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Unterhalt, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hiddemann, W |
| 773 0# - HOST ITEM ENTRY | |
| Title | Leukemia |
| Related parts | vol. 23 |
| -- | no. 1 |
| -- | p. 153-61 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1038/leu.2008.261">https://doi.org/10.1038/leu.2008.261</a> |
| Public note | Available from publisher's website |
No items available.